Regulation of iron absorption in Hfe mutant mice

被引:67
作者
Ajioka, RS
Levy, JE
Andrews, NC
Kushner, JP
机构
[1] Univ Utah, Sch Med, Div Hematol, Dept Internal Med, Salt Lake City, UT 84132 USA
[2] Harvard Univ, Childrens Hosp, Dept Pediat, Div Hematol Oncol, Cambridge, MA 02138 USA
[3] Howard Hughes Med Inst, Chevy Chase, MD USA
[4] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
关键词
D O I
10.1182/blood-2001-11-0037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hereditary hemochromatosis is most commonly caused by homozygosity for a point mutation (C282Y) in the human hemochromatosis gene (HFE). The mechanism by which HFE regulates iron absorption is not known, but the C282Y mutation results in loss of cell surface expression of the human hemachromatosis protein (HFE) and hyperabsorption of iron by the duodenal enterocyte. Mice homozygous for a deletion in the mouse hemochromatosis gene (Hfe) or a mutation equivalent to that seen in human hereditary hemochromatosis (C282Y) were compared with wild-type animals for their ability to regulate iron absorption. Both mutant strains hyper-absorbed Fe-59 administered by gavage. Feeding a diet supplemented with carbonyl iron resulted in a more than 5-fold reduction of 59Fe absorption in both wild-type and mutant mouse strains. Similarly, the iron loading associated with age in Hfe mutant mice resulted in nearly a 4-fold reduction in iron absorption. When mice were stimulated to absorb iron either by depleting iron stores or by inducing erythropoiesis, wild type and Hfe mutant strains increased absorption to similar levels, approximately 5-fold over control values. Our data indicate that Hfe mutant mice retain the ability to regulate iron absorption. Mouse hemachromatosis protein (Hfe) plays a minor role in down-regulation but does not influence the up-regulation of iron absorption. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:1465 / 1469
页数:5
相关论文
共 34 条
[11]   HEREDITARY HEMOCHROMATOSIS - DIAGNOSIS IN SIBLINGS AND CHILDREN [J].
EDWARDS, CQ ;
CARROLL, M ;
BRAY, P ;
CARTWRIGHT, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (01) :7-13
[12]  
EDWARDS CQ, 1982, CLIN HAEMATOL, V11, P411
[13]   The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding [J].
Feder, JN ;
Penny, DM ;
Irrinki, A ;
Lee, VK ;
Lebrón, JA ;
Watson, N ;
Tsuchihashi, Z ;
Sigal, E ;
Bjorkman, PJ ;
Schatzman, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1472-1477
[14]   A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408
[15]   The hemochromatosis founder mutation in HLA-H disrupts beta(2)-microglobulin interaction and cell surface expression [J].
Feder, JN ;
Tsuchihashi, Z ;
Irrinki, A ;
Lee, VK ;
Mapa, FA ;
Morikang, E ;
Prass, CE ;
Starnes, SM ;
Wolff, RK ;
Parkkila, S ;
Sly, WS ;
Schatzman, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) :14025-14028
[16]  
FINCH C, 1994, BLOOD, V84, P1697
[17]  
Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383
[18]   Cloning and characterization of a mammalian proton-coupled metal-ion transporter [J].
Gunshin, H ;
Mackenzie, B ;
Berger, UV ;
Gunshin, Y ;
Romero, MF ;
Boron, WF ;
Nussberger, S ;
Gollan, JL ;
Hediger, MA .
NATURE, 1997, 388 (6641) :482-488
[19]   Reciprocal regulation of HFE and Nramp2 gene expression by iron in human intestinal cells [J].
Han, O ;
Fleet, JC ;
Wood, RJ .
JOURNAL OF NUTRITION, 1999, 129 (01) :98-104
[20]   IRON METABOLISM - IRON STORES IN MAN AS MEASURED BY PHLEBOTOMY [J].
HASKINS, D ;
STEVENS, AR ;
FINCH, S ;
FINCH, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1952, 31 (06) :543-547